Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
The new therapeutics include a device to reduce the incidence of sepsis in combat-injured soldiers, which is being advanced under a contract from the Defense Advanced Research Projects Agency (DARPA). The initial members of the Aethlon Sepsis & Inflammation Scientific Advisory Board are Irshad Chaudry, Ph.D., Charles J. Fisher, Jr., MD and Geert Schmid-Schonbein, Ph.D.
